These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 36210838)
1. Neutrophils in ANCA-associated vasculitis: Mechanisms and implications for management. Ge S; Zhu X; Xu Q; Wang J; An C; Hu Y; Yang F; Wang X; Yang Y; Chen S; Jin R; Li H; Peng X; Liu Y; Xu J; Zhu M; Shuai Z Front Pharmacol; 2022; 13():957660. PubMed ID: 36210838 [TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society. Harabuchi Y; Kishibe K; Tateyama K; Morita Y; Yoshida N; Okada M; Kunimoto Y; Watanabe T; Inagaki A; Yoshida T; Imaizumi M; Nakamura T; Matsunobu T; Kobayashi S; Iino Y; Murakami S; Takahashi H; Tono T Auris Nasus Larynx; 2021 Feb; 48(1):2-14. PubMed ID: 32768313 [TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: A retrospective analysis of 455 patients from a single center in China. Chang DY; Li ZY; Chen M; Zhao MH Semin Arthritis Rheum; 2019 Feb; 48(4):701-706. PubMed ID: 29887327 [TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention. Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P Am J Kidney Dis; 2013 Dec; 62(6):1176-87. PubMed ID: 23810690 [TBL] [Abstract][Full Text] [Related]
8. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis. Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364 [TBL] [Abstract][Full Text] [Related]
9. Performance of MPO-ANCA and PR3-ANCA immunoassays for the stratification of specific ANCA-associated vasculitis: A systematic review and meta-analysis. Walker BS; Peterson LK; Koening C; White SK; Schmidt RL; Tebo AE Autoimmun Rev; 2022 Jun; 21(6):103100. PubMed ID: 35452854 [TBL] [Abstract][Full Text] [Related]
10. Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study. Kawasaki A; Hasebe N; Hidaka M; Hirano F; Sada KE; Kobayashi S; Yamada H; Furukawa H; Yamagata K; Sumida T; Miyasaka N; Tohma S; Ozaki S; Matsuo S; Hashimoto H; Makino H; Arimura Y; Harigai M; Tsuchiya N PLoS One; 2016; 11(5):e0154393. PubMed ID: 27166610 [TBL] [Abstract][Full Text] [Related]
11. Neutrophil Extracellular Traps in ANCA-Associated Vasculitis. Söderberg D; Segelmark M Front Immunol; 2016; 7():256. PubMed ID: 27446086 [TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study. Kim SM; Choi SY; Kim SY; Kim J Rheumatol Int; 2019 Nov; 39(11):1919-1926. PubMed ID: 31552433 [TBL] [Abstract][Full Text] [Related]
13. ANCA associated vasculitis in patients from Saudi Arabia. Al Arfaj AS; Khalil N Pak J Med Sci; 2018; 34(1):88-93. PubMed ID: 29643885 [TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type. Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U; Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483 [TBL] [Abstract][Full Text] [Related]
15. Environmental factors influencing the risk of ANCA-associated vasculitis. Zhao WM; Wang ZJ; Shi R; Zhu YY; Zhang S; Wang RF; Wang DG Front Immunol; 2022; 13():991256. PubMed ID: 36119110 [TBL] [Abstract][Full Text] [Related]
16. Primary Vasculitis in Childhood: GPA and MPA in Childhood. Jariwala MP; Laxer RM Front Pediatr; 2018; 6():226. PubMed ID: 30167431 [TBL] [Abstract][Full Text] [Related]
17. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets. Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559 [TBL] [Abstract][Full Text] [Related]
19. Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide? Wallace ZS; Stone JH Front Immunol; 2019; 10():2855. PubMed ID: 31867013 [TBL] [Abstract][Full Text] [Related]
20. Neutrophils from ANCA-associated vasculitis patients show an increased capacity to activate the complement system via the alternative pathway after ANCA stimulation. Ohlsson S; Holm L; Hansson C; Ohlsson SM; Gunnarsson L; Pettersson Å; Skattum L PLoS One; 2019; 14(6):e0218272. PubMed ID: 31216309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]